Athersys Company Profile
Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.
As represented by its name, (Athersys - derived from advanced therapeutic systems), the Company is committed to developing novel therapeutic products that deliver substantial improvements over existing therapies through the application and utilization of its advanced, proprietary technology platforms.
Through internal development and acquisition of key technologies, Athersys has established a unique blend of competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry, and pharmacology. The Company has fully integrated pre-clinical drug discovery and development capabilities, and is focused on advancing a portfolio of therapeutic development programs into the clinic.
3201 Carnegie Avenue
United States of America
Email: firstname.lastname@example.org., email@example.com
Athersys, Inc. (NASDAQ:ATHX) Q2 2014 Earnings Conference Call August 11, 2014, 04:30 PM ET Executives Lisa Wilson - Investor Relations, In-Site Communications Gil Van Bokkelen - Chairman and Chief...
CLEVELAND, Nov. 10, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended September 30, 2014. Highlights of the third quarter of 2014 ...
CLEVELAND, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2014. Highlights of the second quarter of 2014 and ...
CLEVELAND, Oct. 17, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2014 financial results at approximately 4:00 PM (Eastern Time) on Monday, November 10, 2014, a...
CLEVELAND, Sept. 29, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO will present at the 4th Annual Partnering Forum, part of the Stem Ce...
CLEVELAND, July 16, 2014 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2014 financial results at approximately 4:00 PM (Eastern Time) on Monday, August 11, 2014, an...
Drugs and Medications
Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...
Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...
Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...
More Information about "Athersys" on BioPortfolio
We have published hundreds of Athersys news stories on BioPortfolio along with dozens of Athersys Clinical Trials and PubMed Articles about Athersys for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys Companies in our database. You can also find out about relevant Athersys Drugs and Medications on this site too.